MRKR · All filings · Read this filing
What changed 10-Q
Item 5. Other Information
2021-08-10 compared with 2021-05-12 · 3 added, 1 removed, 24 unchanged (14% of the section changed)
8 unchanged sentences
Certification of Chief Financial Officer Pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1933, as amended.
−Removed: Certification of Chief Executive Officer Pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1933, as amended.
+Added: Certification of Chief Executive Officer and Principal Executive Officer pursuant to 18 U.S.C.
+Added: 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
Certification of Chief Financial Officer and Principal Financial Officer pursuant to 18 U.S.C.
9 unchanged sentences
In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
+Added: August 10, 2021
MARKER THERAPEUTICS, INC.
3 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.